Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

NCT02585895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

BIOLOGICAL: Evolocumab
PROCEDURE: Low-density Lipoprotein Cholesterol (LDL-C) Apheresis

Sponsor

Amgen